EcoDrugPlus

B2 Bradykinin Receptor-Like

Ensembl ID : ENSECRG00000012260
Gene Symbol: LOC114666351
2 Cross references
287 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSECRG00000005594
Gene Symbol: BCL2
3 Cross references
228 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSECRG00000013046
Gene Symbol: BCL2L1
3 Cross references
288 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSECRG00000017414
Gene Symbol: BCR
3 Cross references
288 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSECRG00000013113
Gene Symbol: BTK
3 Cross references
208 Possible Orthologues:

C-C Motif Chemokine Receptor 9

Ensembl ID : ENSECRG00000003795
Gene Symbol: CCR9
3 Cross references
265 Possible Orthologues:

C-X-C Motif Chemokine Receptor 1

Ensembl ID : ENSECRG00000016885
Gene Symbol: CXCR1
3 Cross references
275 Possible Orthologues:

C-X-C Motif Chemokine Receptor 4

Ensembl ID : ENSECRG00000008578
Gene Symbol: CXCR4
3 Cross references
218 Possible Orthologues:

C-Reactive Protein

Ensembl ID : ENSECRG00000018128
Gene Symbol: CRP
3 Cross references
588 Possible Orthologues:

Cf Transmembrane Conductance Regulator

Ensembl ID : ENSECRG00000011130
Gene Symbol: CFTR
3 Cross references
217 Possible Orthologues:

Dna Methyltransferase 1

Ensembl ID : ENSECRG00000016149
Gene Symbol: DNMT1
3 Cross references
212 Possible Orthologues:

Dna Topoisomerase Ii Beta

Ensembl ID : ENSECRG00000016352
Gene Symbol: TOP2B
3 Cross references
210 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).